Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Apyx Medical Corporation (APYX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.83+0.63 (+6.18%)
At close: 04:00PM EDT
10.83 0.00 (0.00%)
After hours: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close10.20
Open10.47
Bid6.66 x 1100
Ask12.43 x 800
Day's Range10.39 - 10.99
52 Week Range3.01 - 17.50
Volume83,905
Avg. Volume799,551
Market Cap373.344M
Beta (5Y Monthly)1.38
PE Ratio (TTM)N/A
EPS (TTM)-0.47
Earnings DateAug 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for APYX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Apyx Medical Corporation
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • Business Wire

    Apyx Medical Corporation Releases Environmental, Social and Governance Data in New Tear Sheet

    CLEARWATER, Fla., July 27, 2022--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of proprietary helium plasma and radiofrequency technology products marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced its first reporting of environmental, social and governance ("ESG") data via a newly released tear sheet. This data provides context to the Company’s ESG goals and priorities important to its business

  • Benzinga

    Apyx Medical's Renuvion Scores FDA Approval To Eliminate Sagging Neck

    The FDA has granted 510(k) clearance for Apyx Medical Corporation's (NASDAQ: APYX) Renuvion for subcutaneous dermatological and aesthetic procedures to improve the appearance of lax skin in the neck and submental region. Renuvion is a proprietary helium plasma and radiofrequency technology. Related: Apyx Medical Posts Encouraging Data From Renuvion Device In Sagging Skin. This clearance offers a new option for physicians and patients to improve loose skin on the neck and submental region. With t

  • PR Newswire

    RENUVION® CLEARED BY FDA FOR NECK LAXITY PROCEDURES OFFERING PATIENTS A MINIMALLY INVASIVE OPTION TO ELIMINATE SAGGING NECK

    Apyx Medical Corporation (NASDAQ: APYX), the manufacturer of Renuvion®, a proprietary helium plasma and radiofrequency technology, announces the receipt of 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for the use of Renuvion for use in subcutaneous dermatological and aesthetic procedures to improve the appearance of lax skin in the neck and submental region. This clearance offers a new option for physicians and patients to improve loose skin on the neck and submental regio

Advertisement
Advertisement